M
Michael E. Sughrue
Researcher at University of Oklahoma Health Sciences Center
Publications - 320
Citations - 8960
Michael E. Sughrue is an academic researcher from University of Oklahoma Health Sciences Center. The author has contributed to research in topics: Medicine & Meningioma. The author has an hindex of 48, co-authored 284 publications receiving 7058 citations. Previous affiliations of Michael E. Sughrue include University of Oklahoma & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Alien limb syndrome secondary to multimodal treatment of recurrent oligodendroglioma.
TL;DR: A 41-year-old man who experienced alien limb syndrome as a complication of treatment for recurrent Grade III oligodendroglioma of the right parietal lobe is presented.
Posted ContentDOI
Interventional Neurorehabilitation for Promoting Functional Recovery Post-Craniotomy: A Proof-of-Concept
Anujan Poologaindran,Anujan Poologaindran,Christos Profyris,Isabella M. Young,Nicholas B. Dadario,Syed A. Ahsan,Kassem Chendeb,Robert G. Briggs,Charles Teo,Rafael Romero-Garcia,John Suckling,John Suckling,Michael E. Sughrue +12 more
TL;DR: In this article, the safety profile for interventional neurorehabilitation following craniotomy was established for connectome-based therapeutic brain stimulation to drive cortical reorganization and promote functional recovery post-craniotomy.
Journal ArticleDOI
End-of-Life Care Options and Decision Making for Older Patients With Malignant Brain Tumors.
Journal ArticleDOI
Laser Interstitial Thermal Therapy for Metastatic Melanoma After Failed Radiation Therapy: A Case Series.
Ali H. Palejwala,Kyle P. O'Connor,Camille K Milton,Panayiotis E. Pelargos,Chad A. Glenn,Bradley N. Bohnstedt,Ozer Algan,Michael E. Sughrue +7 more
TL;DR: LITT is a safe therapy, with few complications and short hospital stays, when compared to the literature for metastatic melanoma.
Journal ArticleDOI
An agile, data‐driven approach for target selection in rTMS therapy for anxiety symptoms: Proof of concept and preliminary data for two novel targets
Isabella M. Young,Hugh M. Taylor,Peter J. Nicholas,Alana E. Mackenzie,Onur Tanglay,Nicholas B. Dadario,Karol Osipowicz,Ethan J Davis,Stéphane Doyen,Charles Teo,Michael E. Sughrue +10 more
TL;DR: In this article , a proof of concept for an agile target selection paradigm based on using connectomic methods that can be used to detect patient-specific abnormal functional connectivity, guide treatment aimed at the most abnormal regions, and optimize the rapid development of new hypotheses for future study.